{"id":"https://openalex.org/W2147674804","doi":null,"title":"Increasing HDL cholesterol with extended-release nicotinic acid: from promise to practice.","display_name":"Increasing HDL cholesterol with extended-release nicotinic acid: from promise to practice.","publication_year":2004,"publication_date":"2004-07-01","ids":{"openalex":"https://openalex.org/W2147674804","mag":"2147674804","pmid":"https://pubmed.ncbi.nlm.nih.gov/15554597"},"language":"en","primary_location":{"id":"pmid:15554597","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15554597","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Netherlands journal of medicine","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064131836","display_name":"Rakesh S. Birjmohun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"R S Birjmohun","raw_affiliation_strings":["Department of Vascular Medicine, Academic Medical Centre, PO Box 22660, 1100 DD Amsterdam, the Netherlands. r.s.birjmohun@amc.uva.nl","Department of Vascular Medicine, Academic Medical Centre, PO Box 22660, 1100 DD Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Vascular Medicine, Academic Medical Centre, PO Box 22660, 1100 DD Amsterdam, the Netherlands. r.s.birjmohun@amc.uva.nl","institution_ids":["https://openalex.org/I2802928900"]},{"raw_affiliation_string":"Department of Vascular Medicine, Academic Medical Centre, PO Box 22660, 1100 DD Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015459043","display_name":"Barbara A. Hutten","orcid":"https://orcid.org/0000-0002-9243-0037","observed_orcids":["https://orcid.org/0000-0002-9243-0037"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B A Hutten","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077848934","display_name":"John J.P. Kastelein","orcid":"https://orcid.org/0000-0003-2018-4532","observed_orcids":["https://orcid.org/0000-0003-2018-4532"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J J P Kastelein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5081557648","display_name":"Erik S.G. Stroes","orcid":"https://orcid.org/0000-0001-9555-6260","observed_orcids":["https://orcid.org/0000-0001-9555-6260","https://orcid.org/0009-0000-7584-7677"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E S G Stroes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4502,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.84345075,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"62","issue":"7","first_page":"229","last_page":"34"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/niaspan","display_name":"Niaspan","score":0.796999990940094},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.9459999799728394},{"id":"https://openalex.org/keywords/statin-combination-therapy","display_name":"statin combination therapy","score":0.7239999771118164},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.7020000219345093},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lipoprotein-a","display_name":"lipoprotein(a)","score":0.9990000128746033},{"id":"https://openalex.org/keywords/flushing","display_name":"flushing","score":0.7630000114440918},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8939999938011169},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.8880000114440918},{"id":"https://openalex.org/keywords/cardiovascular-disease-prevention","display_name":"cardiovascular disease prevention","score":0.7139999866485596},{"id":"https://openalex.org/keywords/serum-lipids","display_name":"serum lipids","score":0.6830000281333923}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9249396324157715},{"id":"https://openalex.org/C2780092750","wikidata":"https://www.wikidata.org/wiki/Q134658","display_name":"Niacin","level":2,"score":0.62082839012146},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.578033447265625},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.5770678520202637},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.5687063336372375},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5649459958076477},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.48526737093925476},{"id":"https://openalex.org/C2780541478","wikidata":"https://www.wikidata.org/wiki/Q410020","display_name":"High-density lipoprotein","level":3,"score":0.4497043788433075},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.436354398727417},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.4283539056777954},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4130121171474457},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.41163116693496704},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4108031392097473},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3325870633125305},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3297109603881836},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.26340192556381226}],"mesh":[{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003324","descriptor_name":"Coronary Artery Disease","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003324","descriptor_name":"Coronary Artery Disease","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008076","descriptor_name":"Cholesterol, HDL","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009525","descriptor_name":"Niacin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009525","descriptor_name":"Niacin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009525","descriptor_name":"Niacin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":4,"locations":[{"id":"pmid:15554597","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15554597","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Netherlands journal of medicine","raw_type":"Journal Article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/842068c9-8e27-4873-b34b-61d1233dfb82","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/increasing-hdl-cholesterol-with-extendedrelease-nicotinic-acid-from-promise-to-practice(842068c9-8e27-4873-b34b-61d1233dfb82).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Netherlands journal of medicine, 62(7), 229 - 234. Van Zuiden Communications BV","raw_type":"info:eu-repo/semantics/other"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/986f8620-3cff-43ed-8080-fbcc9bc5be71","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/986f8620-3cff-43ed-8080-fbcc9bc5be71","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Birjmohun, R S, Hutten, B A, Kastelein, J J P & Stroes, E S G 2004, 'Increasing HDL cholesterol with extended-release nicotinic acid: from promise to practice', Netherlands journal of medicine, vol. 62, no. 7, pp. 229-234.","raw_type":"info:eu-repo/semantics/review"},{"id":"mag:2147674804","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15554597","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1502524639","https://openalex.org/W1930168886","https://openalex.org/W1965545632","https://openalex.org/W1973178110","https://openalex.org/W1981670728","https://openalex.org/W1988179941","https://openalex.org/W2014894063","https://openalex.org/W2027750202","https://openalex.org/W2028737910","https://openalex.org/W2045371315","https://openalex.org/W2053599662","https://openalex.org/W2055318521","https://openalex.org/W2070855777","https://openalex.org/W2077760013","https://openalex.org/W2078489774","https://openalex.org/W2078578691","https://openalex.org/W2081767391","https://openalex.org/W2090809780","https://openalex.org/W2094768566","https://openalex.org/W2117092539","https://openalex.org/W2119065130","https://openalex.org/W2145034104","https://openalex.org/W2156068102","https://openalex.org/W2277700133","https://openalex.org/W2328529137","https://openalex.org/W2341665659"],"related_works":["https://openalex.org/W2147326058","https://openalex.org/W2042690713","https://openalex.org/W1916117934","https://openalex.org/W2141086292","https://openalex.org/W7097046239","https://openalex.org/W2074972512","https://openalex.org/W4247178164","https://openalex.org/W2160478996","https://openalex.org/W2100768911","https://openalex.org/W2383562458"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1],"inverse":[2],"relation":[3],"between":[4],"high-density":[5],"lipoprotein":[6,70],"cholesterol":[7,71],"(HDL-C)":[8],"and":[9,42,60,75,83,98,110,163,172,181],"cardiovascular":[10,211],"(CV)":[11],"disease":[12],"underscores":[13],"the":[14,20,27,35,43,143,191,207],"need":[15],"for":[16,210],"clinical":[17],"evaluation":[18],"of":[19,22,29,37,45,96,126,131,142,193],"effect":[21,125,192],"HDL-C":[23,87,133,156],"increasing":[24],"drugs":[25],"on":[26,39,128,161,187],"prevalence":[28],"CV":[30,188],"disease.":[31],"METHODS:":[32],"We":[33],"review":[34],"efficacy":[36],"Niaspan":[38,97,117,136,153,165,196],"serum":[40],"lipids":[41],"occurrence":[44],"side":[46],"effects":[47,160],"either":[48],"alone":[49],"or":[50],"in":[51,55,105,108,112,140,176],"combination":[52,95,150,204],"with":[53,116,157,170,178,195],"statins,":[54],"randomised":[56],"controlled":[57],"trials":[58,63],"(RCT)":[59],"comparative":[61],"cohort":[62],"(CCT).":[64],"RESULTS:":[65],"In":[66,91],"four":[67,92],"RCTs,":[68],"low-density":[69],"(LDL-C),":[72],"triglycerides":[73],"(TG)":[74],"lipoprotein(a)":[76],"(Lp(a))":[77],"were":[78],"decreased":[79],"by":[80,89],"13,":[81],"26,":[82],"17%,":[84],"respectively,":[85],"whereas":[86],"increased":[88],"18%.":[90],"CCTs":[93],"a":[94,122,129],"statins":[99,171,194],"showed":[100],"an":[101],"additional":[102,124,147],"22%":[103],"reduction":[104],"LDL-C,":[106],"8%":[107],"TG":[109,162],"6%":[111],"Lp(a)":[113],"levels,":[114],"compared":[115],"monotherapy.":[118],"Statin":[119],"therapy":[120],"had":[121],"minor":[123],"1%":[127],"total":[130],"25%":[132],"increase":[134],"during":[135,149],"treatment.":[137],"Flushes":[138],"occurred":[139],"69%":[141],"patients":[144,177],"without":[145],"any":[146],"toxicity":[148],"therapy.":[151],"CONCLUSION:":[152],"effectively":[154],"raises":[155],"concomitant":[158],"beneficial":[159],"LDL-C.":[164],"can":[166,205],"be":[167],"combined":[168,179],"safely":[169],"is":[173],"also":[174],"effective":[175],"dyslipidaemia":[180],"type":[182],"2":[183],"diabetes":[184],"mellitus.":[185],"Trials":[186],"endpoints":[189],"evaluating":[190],"are":[197],"urgently":[198],"needed":[199],"to":[200],"settle":[201],"whether":[202],"this":[203],"confirm":[206],"high":[208],"expectations":[209],"outcome.":[212]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}